TOWNSEND RICHARD NOLAN (Chief Executive Officer) sold 13.9% of their position (55K shares) of LEXEO THERAPEUTICS, INC. on the open market
Open‑market sale worth $313.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/7/2026ACC: 0001995218-26-000009
DirectorOfficer· Chief Executive Officer
Since Feb 2026
-55K
Net shares
Net seller
$313.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
55K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−55K
Price / share
$5.69
Trade value
$313.14K
% of position
13.9%
4/6/2026
395.11K→340.11K
Total
Net shares
−55K
Net value
-$313.14K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/6/2026 | S · Sale | −55K | $5.69 | $313.14K | 13.9% | 395.11K | 340.11K |
| Total | −55K | -$313.14K | ||||||
Derivative Transactions0
No derivative transactions reported